Accredited official statistics

MRSA, MSSA, Gram-negative bacteraemia and CDI: quarterly report

Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.

• From: UK Health Security Agency
• Published: 14 October 2021
• Last updated: 6 November 2024 — See all updates

Applies to England

Documents

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2024)

Ref: GOV-17381

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, data up to April to June 2024

Ref: GOV-17381

HTML

Accompanying data for quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to and including June 2024)

Ref: GOV-17381

ODS, 81.7 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to January to March 2024)

Ref: GOV-16938

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2024

Ref: GOV-16938

HTML

Accompanying data for quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to January to March 2024)

Ref: GOV-16938

ODS, 78.8 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2023)

Ref: GOV-16489

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2023

Ref: GOV-16489

HTML

Accompanying data for quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2023)

Ref: GOV-16489

ODS, 76.6 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2023)

Ref: GOV-16082

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, July to September 2023

Ref: GOV-16082

HTML

Accompanying data for quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2023)

Ref: GOV-16082

ODS, 75.9 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2023)

Ref: GOV-15559

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2023

Ref: GOV-15559

HTML

Accompanying data for quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2023)

Ref: GOV-15559

ODS, 72.4 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to January to March 2023)

Ref: GOV-15011

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2023

Ref: GOV-15011

HTML

Accompanying data for quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to January to March 2023)

Ref: GOV-15011

ODS, 72.4 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2022)

Ref: GOV-14531

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2022

Ref: GOV-14531

HTML

Accompanying data for quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2022)

Ref: GOV-14531

ODS, 66.8 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2022)

Ref: GOV-14099

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, July to September 2022

Ref: GOV-14099

HTML

Accompanying data for quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2022)

Ref: GOV-14099

ODS, 65.4 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2022)

Ref: GOV-13395

HTML

Accompanying data for quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2022)

Ref: GOV-13395

ODS, 66.2 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2022

Ref: GOV-13395

HTML

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2022)

HTML

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to January to March 2022)

Ref: UKHSA publications gateway number GOV-12644

ODS, 59.1 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2022 (text version)

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2022 (print version)

Ref: UKHSA publications gateway number GOV-12644

PDF, 458 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections data (up to October to December 2021)

HTML

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to October to December 2021)

Ref: UKHSA publication gateway number GOV-11768

PDF, 1.13 MB, 29 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to October to December 2021)

Ref: UKHSA publication gateway number GOV-11768

ODS, 57.7 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2021 (text version)

Ref: UKHSA publication gateway number GOV-11768

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2021 (print version)

Ref: UKHSA publication gateway number GOV-11768

PDF, 396 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to July to September 2021)

Ref: UKHSA - Gateway GOV - 10754

PDF, 463 KB, 30 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to July to September 2021)

ODS, 55.3 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, July to September 2021

https://khub.net/documents/135939561/174099494/Quarterly+infographic+-+MRSA%2C+MSSA+and+Gram-negative+bacteraemia+and+CDI+-+July+to+September+2021.pdf/7172e2b8-7239-dad0-6515-53e2ae41d674

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to April to June 2021)

Ref: UKHSA- Gateway GOV-10037

PDF, 1.55 MB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Accompanying data for quarterly epidemiological commentary: MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection data (up to April to June 2021)

ODS, 49.1 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2021

https://khub.net/documents/135939561/174099494/QEC+infographic+April+to+June+2021.pdf/9130098a-ef71-14f1-b855-8a7cce04d3eb

Details

Further Information

These official statistics were independently reviewed by the Office for Statistics Regulation in May 2022. They comply with the standards of trustworthiness, quality and value in the Code of Practice for Statistics and should be labelled ‘accredited official statistics’. Accredited official statistics are called National Statistics in the Statistics and Registration Service Act 2007. Further explanation of accredited official statistics can be found on the Office for Statistics Regulation website.

From September 2017

The commentaries contain national aggregated data and an overview of the trends in the mandatory reports of healthcare associated infection (HCAI) – meticillin resistant Staphylococcus aureus (MRSA), meticillin susceptible Staphylococcus aureus (MSSA) and Gram-negative bacteraemia and Clostridioides difficile (C. difficile) infection – over recent quarters.

For previous quarterly commentaries and associated data please see:

• June 2019 to March 2021

• June 2018 to March 2019

• September 2013 to March 2018

Older quarterly commentaries and associated data are also available from the UK Government Web Archive.

Enquiries or feedback

For any enquiries or feedback on these reports, or to request copies of any web-based reports in PDF format, please contact [email protected]

Published 14 October 2021
Last updated 6 November 2024 + show all updates

1. 6 November 2024

   Added back missing sections to the report which were accidentally omitted during the publishing process.

2. 10 October 2024

   Added data, report and infographic for April to June 2024.

3. 11 September 2024

   Small decimal point differences in the overall and community-onset rates have been made in the January to March 2024 quarterly report, as quarter 4 of the financial year 2023 to 2024 national population estimate did not account for the leap year. These corrections do not affect the direction of trends.

4. 11 July 2024

   Added data, report and infographic for January to March 2024.

5. 11 April 2024

   Added data, report and infographic for October to December 2023.

6. 25 January 2024

   Added data, report and infographic for July to September 2023.

7. 5 October 2023

   Added data, report and infographic for April to June 2023.

8. 6 July 2023

   Added data, report and infographic for January to March 2023. Also corrected heading in October to December 2022 report.

9. 6 April 2023

   Added data, report and infographic for October to December 2022.

10. 26 January 2023

    Added data, report and infographic for July to September 2022.

11. 6 October 2022

    Added report, accompanying data and infographic for April to June 2022.

12. 7 July 2022

    Added report for January to March 2022 and accompanying data.

13. 7 April 2022

    Added October to December 2021 report, spreadsheet and infographic.

14. 27 January 2022

    Added July to September 2021 quarterly epidemiological commentary and accompanying data.

15. 14 October 2021

    Added April to June 2021 infographic.

16. 14 October 2021

    First published.